Open AccessCrizotinib plus erlotinib overcomes osimertinib resistance in a seriously-ill non-small cell lung cancer patient with acquired MET amplification
Author(s) -
Zhenze Zhao,
Songping Wang,
Lei Sun,
Youxin Ji
Publication year - 2020
Publication title -
chinese medical journal/chinese medical journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.537
H-Index - 63
eISSN - 2542-5641
pISSN - 0366-6999
DOI - 10.1097/cm9.0000000000001184
Subject(s) - crizotinib , medicine , osimertinib , erlotinib , t790m , lung cancer , adenocarcinoma , carboplatin , pemetrexed , oncology , epidermal growth factor receptor , afatinib , gefitinib , radiology , chemotherapy , cancer , malignant pleural effusion , cisplatin